Acme United Corp (ACU) Reports Full Year Earnings with Strong Margin Growth
-
Net Sales: $191.5 million for the year ended December 31, 2023, a slight decrease from $194.0 million in 2022.
-
Net Income: Excluding the sale of product lines, net income for 2023 was $8.2 million, a significant increase from $3.0 million in 2022.
-
Earnings Per Share: Diluted EPS for 2023 was $4.86, including the sale of Camillus and Cuda, compared to $0.82 in 2022.
-
Gross Margin: Improved to 37.7% for the year, up from 32.8% in the previous year.
-
Free Cash Flow: Reached a record $24 million, including a $5 million reduction in inventory.
-
Debt Reduction: Bank debt less cash was reduced to $19.0 million from $55.0 million as of December 31, 2022.
-
Divestiture Impact: The sale of Camillus and Cuda product lines resulted in an after-tax gain of approximately $9.6 million.
On March 1, 2024, Acme United Corp (ACU) released its 8-K filing, detailing the financial results for the fourth quarter and full year ended December 31, 2023. The company, a leading supplier of first aid and medical products, as well as cutting technology, reported a slight decrease in net sales but a substantial increase in net income and earnings per share, largely due to strategic divestitures and cost-saving measures.
Financial Performance and Strategic Moves
Acme United's net sales for 2023 were $191.5 million, a 1% decrease from the previous year, attributed to the sale of the Camillus and Cuda product lines and a soft European economy. Despite this, the company's net income, excluding the impact of the sale, was $8.2 million, or $2.23 per diluted share, compared to $3.0 million, or $0.82 per diluted share, in 2022. Including the sale, net income was $17.8 million, or $4.86 per diluted share.
The divestiture of the Camillus and Cuda product lines to GSM Holdings, Inc. for $19.8 million allowed the company to focus on its core businesses and reduce its debt by $13 million. This strategic move, along with inventory reduction and cost-saving initiatives, contributed to a record free cash flow of $24 million and a strengthened balance sheet.
Operational Highlights and Future Outlook
Chairman and CEO Walter C. Johnsen highlighted the company's achievements, stating,
We had an outstanding year of strong earnings and achievements in 2023. The sale of Cuda and Camillus in the fourth quarter enabled the Company to focus on our core businesses and reduced our debt by $13 million."
Johnsen also noted the successful implementation of cost reduction and productivity initiatives that generated approximately $6.5 million in savings, surpassing the initial target of $5 million.